Recently, many of us have been hearing about Monkeypox (MPXV). After making it through two and a half years of COVID, it makes sense to feel uneasy. Especially, when we are seeing it spread among the LGBTQ+ community. But we’re smarter now. We’ve learned about how diseases spread, and we’re prepared to do what it takes to stay safe. We’re learning all we can, and we’re gonna keep you updated about what we’ve learned. Here’s what we know so far:
During August–October 2022, CDC provided clinical consultation for 57 hospitalized patients with severe manifestations of monkeypox, most of whom were Black men with AIDS. Delays were observed in initiation of monkeypox-directed therapies. Twelve patients died, and monkeypox was a cause of death or contributing factor in five patients to date, with several other deaths still under investigation.
Clinicians should consider early treatment with available therapeutics for those at risk for severe monkeypox disease, particularly patients with AIDS. Engaging all persons with HIV in care remains a critical public health priority.
Read the report from the CDC here.